Melbourne, Australia Wednesday, May 15 - Saturday, May 18, 2024
Registration is closed - This meeting has concluded
Meeting Location:
Melbourne Convention Exhibition Centre 1 Convention Centre Place Melbourne, Victoria 3006
The meeting app is now available! Download the app in your phone's app store or access the web version here ** Note that the program book is being finalized and will be available in the app soon. Updates to the schedule are still being made as the meeting approaches. Check regularly for updates.
INSAR 2024 will be held in a central location, within walking distance of several hotels. See information regarding hotels with INSAR room blocks and more on the pages linked below. Please note: You MUST have the address related to your accommodations when applying for your VISA!
Adriana Di Martino, MD, is the founding and research director of the Autism Center at the Child Mind Institute in New York City, USA, where she also serves as a tenured senior research scientist and the Dr. John and Consuela
Phelan Scholar. Dr. Di Martino completed her medical degree and residency training in child psychiatry and pediatric neurology at the University of Cagliari, Italy. She pursued research specialization through a postdoctoral
fellowship at the NYU Langone Medical Center, NYC, USA, and continued as a member of their faculty before joining the Child Mind Institute. Dr. Di Martino has a long-standing research interest in understanding the neurobiological
underpinnings of autism and other neurodevelopmental conditions through brain imaging and a range of other clinical and cognitive approaches. Dr. Di Martino is a prolific and highly cited scholar. Her studies place a particular
emphasis on understanding large scale brain networks and have empirically addressed key methodological and conceptual research challenges in the field. To accelerate the pace of discovery, Dr. Di Martino co-founded and
directed the Autism Brain Imaging Data Exchange (ABIDE) which aggregates and shares over 2000 functional and structural brain imaging data from laboratories around the world. Dr. Di Martino has been also a leader in efforts
aimed to gain a deeper understanding of autism heterogeneity. These include studies examining dimensional inter-individual differences in brain-behavior relationships, exploring novel approaches to subtyping, as well as
recognizing and understanding overlaps in the neural bases of mental health conditions seemingly co-occurring with autism. Dr. Di Martino has received honors and funding support from the National Institute of Health, the
Brain Behavior Research Foundation (formerly NARSAD), the Leon Levy Foundation, the Simons Foundation, and the Eagles Autism Foundation. In addition to her investigative endeavors, Dr. Di Martino is committed to serve the
scientific community more broadly as mentor to early career colleagues and grant reviewer for NIH and other research foundations’ review groups. She is the chair of the Child Psychopathology and Developmental Disorder (CPDD)
NIH study section, and a member of the scientific advisory board for the Autism Science Foundation. More recently, Dr. Di Martino received the fourth “Autismo Senza Frontiere” (Autism Without Borders) award conferred by
the Falanga Foundation, in collaboration with the IRCSS Stella Maris Institute of the University of Pisa, Italy which is particularly meaningful to her because of her origins.
Matthew Siegel, MD is a Professor of Psychiatry and Pediatrics at Tufts University School of Medicine, a Senior Instructor at Harvard Medical School, Chief of Clinical Enterprise for Boston Childrens Hospital Department
of Psychiatry and Behavioral Sciences, and Chief Behavior Health Officer for Franciscan Childrens Hospital. He attended Amherst College, Stanford Medical School and trained at Brown University in child psychiatry, psychiatry,
and pediatrics. Dr. Siegel built a nationally recognized continuum of care, teaching and research to address the behavioral health of youth with autism and other developmental disabilities in Maine. He founded and is the
principal investigator of the Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC), and founded the first U.S. learning health network of hospital psychiatric units serving youth with developmental
disabilities. His research and clinical work have focused on better understanding the phenotypic profiles and clinical needs of youth with profound autism, intense behavior and co-occurring psychiatric disorders. He has
led the creation of the Autism Inpatient Collection, a data resource of over 1500 deeply phenotyped and genetically sequenced participants, heavily weighted to those with profound autism and intense behavior, available
to investigators worldwide through SFARIBase. Dr. Siegel is a federally appointed member of the National Institutes of Health Interagency Autism Coordinating Committee and a lead author of the practice guidelines of the
American Academy of Child and Adolescent Psychiatry for assessment and treatment of youth with autism, and youth with intellectual disability.
Professor Gau is Vice President of the National Taiwan University (NTU) Hospital and a Distinguished Professor of Psychiatry, Psychology, Epidemiology, Brain and Mind Sciences, Clinical Medicine, and Occupational Therapy at NTU, Taiwan. Her research primarily focuses on the psychiatric, genetic, and pharmacoepidemiology of attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). She has co-developed and prepared several Chinese versions of instruments for ADHD and ASD, conducted several studies on pharmacotherapy for ADHD, and been conducting follow-up, family, neuropsychological, neuroimaging, neurophysiological, microbiome, metabolomics, genetic, animal, and cellular (iPSC) studies on these disorders.
She has published over 300 SCI/SSCI articles since 2001 and has presented her work on over 800 occasions, including over 30 keynote and plenary speeches. She received many outstanding research, teaching, and service awards before the COVID-19 pandemic. She received the prestigious 2020 Physician Model Award from the Taiwan Medical Association (Taiwan MA), the 2021 COVID-19 Prevention Human Rights Service Award, the 2022 COVID-19 Prevention Contribution Award from Taipei MA, and the Special Contribution Award for COVID-19 Prevention from Taiwan MA. Furthermore, Professor Gau was honored with the 2023 Human Rights Contribution Award and the 2024 Outstanding Research Award from Taiwan’s National Council of Science and Technology, underscoring her exceptional contributions to her field and society.
Dr. Wenn is passionate about autism, mental health, all things LGBTQIA+ and building autism understanding across the generations, professions and the world. He is a well know author, speaker and poet. Wenn is an Adjunct
Associate Professor with Curtin University, WA, and member of CARG (Curtin University’s Autism Research Group). He has published as a Senior Researcher with Macquarie University, Sydney, NSW, Curtin University WA and The
University of Queensland, Australia. Wenn’s focus has been to highlight the need for co-production in a variety of neurodivergent research, to contribute to the call of the autistic voice: ‘it must be nothing about me without
me’ and to highlight the needs of those who are late in coming to a recognition of their autism as well as the reality that adaptive morphing (masking) has had on mental health. Wenn is a key theorist of the Monotropism
theory of Autism. Wenn resides on a number of boards, including the editorial board for ‘Autism in Adulthood’, the Autism Research Institute (ARI) (US), and The American Autism Ass. As well as being a well-known author,
Wenn is a family man with a love for birds.
